New advanced NMR spectrometer for drug discovery and disease research
600 MHz NMR spectrometer with 1.7mm micro-cryoprobe
This study is all about getting a new, advanced machine to help scientists better understand natural substances from the ocean that could lead to new medicines, which might eventually help patients like you by discovering new treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10632726 on NIH RePORTER |
What this research studies
This research focuses on acquiring a state-of-the-art 600 MHz NMR spectrometer equipped with a micro-cryoprobe to enhance the study of marine natural products and their potential in drug design and synthesis. The new instrument will replace an outdated model, allowing researchers to explore complex biological molecules and identify markers of human diseases more effectively. By improving the sensitivity and throughput of experiments, this research aims to facilitate the discovery of new drug leads and innovative methods for synthesizing drugs. Patients may benefit indirectly through the development of new treatments derived from these research efforts.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that may be treated by new drugs developed from marine natural products.
Not a fit: Patients who are not affected by diseases targeted by the new drug treatments may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drug treatments for various human diseases.
How similar studies have performed: Previous research utilizing advanced NMR spectroscopy has successfully led to the discovery of new drugs and therapeutic methods, indicating a promising potential for this approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Duggan, Brendan Michael — University of California, San Diego
- Study coordinator: Duggan, Brendan Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.